MANISH VIJ,WEST DELHI vs. ACIT, CC-32, DELHI

Q: Which sections of the Income-tax Act were involved?

Section 147, Section 148, Section 68

ITA 1135/DEL/2026Status: DisposedITAT Delhi12 June 2026AY 2015-166 pages

In favour of the assessee: the assessee's appeal was allowed. From the AI summary of this appeal.

AI SummaryAllowed

What did the Tribunal hold?

The Tribunal held that the reassessment proceedings were invalid and quashed them. The Tribunal noted that the case was reopened on the premise that the assessee was identified as an 'exit provider' and not a beneficiary of loss or profit, and therefore, commission income should have been added. However, the addition was made under Section 68 of the Act as unexplained cash credit. The Tribunal found that the facts of the case were squarely covered by the decisions of the Hon'ble Delhi High Court in Ranbaxy Laboratories Ltd. (supra) and other High Courts cited by the assessee. The ratio decidendi is that if the foundational reason for reopening the assessment fails, the reassessment proceedings do not survive, and the Assessing Officer cannot make additions on other issues. Consequently, grounds 1 and 2 of the assessee's appeal were allowed, and the reassessment proceedings were quashed. Other grounds became academic.

What were the facts?

The assessee, Shri Manish Vij, filed an appeal against the order of the CIT(Appeals)-30, New Delhi, dated December 31, 2025. The assessment for Assessment Year 2015-16 was made by the ACIT, Central Circle-32, Delhi, on March 22, 2022, under Section 147 of the Income-tax Act, 1961. The Assessing Officer noted that the assessee had purchased shares of DLFL worth Rs. 1,79,35,696, identified as an 'exit provider, no sale'. The AO considered this amount as unaccounted income, adjusted through bogus capital loss, and added it to the total income under Section 68. The reasons for reopening stated that the assessee was identified as an 'exit provider' and not a beneficiary of loss or profit, implying commission income relatable to Rs. 1,79,35,696 had escaped assessment.

What were the issues?

1. Whether the reassessment proceedings initiated under Section 147 read with Section 148 of the Act are valid and not void ab initio, bad in law, and without jurisdiction. (Question of law and fact, concerning Section 147 and Section 148 of the Income-tax Act, 1961). 2. Whether, when the foundational allegation for reopening (commission income) does not survive, any other additions can be made, as per the law laid down by the Hon'ble Delhi High Court in Ranbaxy Laboratories Limited Vs. CIT. Assessee's Contentions: The assessee argued that the reassessment proceedings were void ab initio and without jurisdiction because the basis for reopening, which was the alleged commission income as an 'exit provider', was not substantiated. The Assessing Officer failed to establish that the transactions were sham or fictitious, or that any commission was earned. The addition made under Section 68 as unaccounted income adjusted through bogus capital loss was not the income for which the assessment was reopened. The assessee relied on the decisions in Ranbaxy Laboratories Ltd. Vs. CIT, CIT Vs. Jet Airways (I) Ltd., PCIT Vs. Meenakshi Overseas (P) Ltd., and PCIT Vs. Mohmed Juned Dadani. Revenue's Contentions: The Senior DR argued that although there should have been a disallowance of loss, the nomenclature of commission added cannot demolish the assessment. She contended that the reasons recorded were clear and unambiguous and the addition was made on the same income.